Levocarnitine propionate hydrochloride(CAS: 119793-66-7)

Levocarnitine propionate hydrochloride (CAS: 119793-66-7) falls under the regulatory guidelines of the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), which includes specific hazard communication requirements. It is also subject to the European Union's Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulations, as well as the U.S. Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) requirements for the import and use of chemical substances.

In the synthesis of levocarnitine propionate hydrochloride (CAS: 119793-66-7), there are several alternatives to consider, such as levocarnitine tartrate or other ester derivatives. Isomers like racemic carnitine or other hydrochloride salts can also be used. Common alternative reagents include propionic anhydride or other suitable carboxylic acid derivatives.

The market for levocarnitine propionate hydrochloride (CAS: 119793-66-7) is growing, driven by its use in dietary supplements and as a pharmaceutical ingredient. Research trends highlight its potential in treating metabolic disorders and as an adjunct in weight management. Emerging studies are focusing on its efficacy in cardiovascular health and neurodegenerative diseases.

Waste containing levocarnitine propionate hydrochloride (CAS: 119793-66-7) should be collected in a closed container and disposed of through professional waste disposal services. It is recommended to neutralize the waste with a suitable base before disposal to minimize environmental impact. Incineration is another method, but it should be conducted under controlled conditions to prevent the release of harmful substances into the environment.